ZeroStack Corp. — fact timeline

ZeroStack Corp. entered into Securities Contribution Agreements and Stockholders' Agreement with Texas Blocker Corp. and certain investors valued at 142,232,948 native tokens in exchange for 9,104,614 Blocker Shares (effective 2026-03-31).

“On March 31, 2026, Texas Blocker Corp., a Texas corporation (“ Texas Blocker ”) that was formed by Daniel Reis-Faria and Dany Vaiman, the Chief Executive Officer and Chief Financial Officer, respectively, of ZeroStack Corp., an Ontario corporation (the “ Company ” or “ ZeroStack ”), for the purpose of facilitating the Exchange (as defined below), entered into securities contribution agreements (the “ Securities Contribution Agreements ”) with certain investors (the “ Investors ”) pursuant to which the Investors contributed an aggregate of 142,232,948 native tokens of the Zero Gravity (0G) blockchain (the “ Tokens ” and each a “ Token ”) in exchange for an aggregate of 9,104,614 shares of common stock, $0.001 par value, of Texas Blocker (the “ Blocker Shares ”) issued on a private placement basis (the “ Contribution ”).”

ZeroStack Corp.: Company changed its name from Flora Growth Corp. to ZeroStack Corp. pursuant to Articles of Amendment (effective 2026-01-29).

“Effective January 29, 2026, Flora Growth Corp. (the "Company") changed its corporate name from "Flora Growth Corp." to "ZeroStack Corp." (the "Name Change") pursuant to Articles of Amendment filed with the Director under the Business Corporations Act (Ontario)”

ZeroStack Corp. entered into Note Settlement Agreement with DeFi Development Corp. (effective 2025-12-29).

“On December 29, 2025, Flora Growth Corp. (the "Company") entered into a note settlement agreement (the "Note Settlement Agreement") with DeFi Development Corp. (the "Holder") pursuant to which the Solana-denominated convertible note issued to the Holder pursuant to the September 19, 2025 securities purchase agreement between the Company and the Holder (the "Note") was settled.”

ZeroStack Corp. received a nasdaq deficiency notice notice regarding board independence (rules 5605(b)(1), 5605(c)(2)(A)).

“August 26, 2025, Nasdaq was informed that because of Mr. Wolkin's passing, the Company is no longer in compliance with certain Corporate Governance Requirements as set forth in Nasdaq Listing Rule 5605. Pursuant to Nasdaq Listing Rule 5605(b)(1), a majority of the Board of a listed company must be comprised of Independent Directors. With Mr. Wolkin's passing, the Board is currently comprised of only four members, Sammy Dorf, Clifford Starke, Edward Woo and Manfred Leventhal. Only two of the four, Mr. Woo and Mr. Leventhal, qualify as Independent Directors. Therefore, the Company's Board is no”

ZeroStack Corp.: Effected a 1-for-39 share consolidation by filing Articles of Amendment to the amended and restated Articles of Incorporation (effective 2025-08-03).

“On August 4, 2025, Flora Growth Corp., a corporation organized under the laws of the Province of Ontario (the " Company "), effected a 1-for-39 share consolidation (the "Share Consolidation") of the Company's issued and outstanding common shares, no par value (the "Common Shares") by the filing of Articles of Amendment to the Company's amended and restated Articles of Incorporation (the "Articles of Amendment") with the Ontario Ministry of Public and Business Service Delivery and Procurement.”

Harold Wolkin was appointed as Director at ZeroStack Corp..

“On August 29, 2024, the Board appointed Mr. Harold Wolkin as an independent director and member of each of the Company's audit committee, compensation committee and nominating and corporate governance committee.”

Kevin Taylor resigned as Director at ZeroStack Corp..

“On August 26, 2024, Mr. Kevin Taylor resigned as a director of the Company.”

Brendan Cahill was appointed as independent director at ZeroStack Corp..

“On May 2, 2024, the Board of Directors (the " Board ") of Flora Growth Corp. (the " Company ") appointed Mr. Brendan Cahill as an independent director and member of each of the Company's audit committee, compensation committee and nominating and corporate governance committee.”

ZeroStack Corp. entered into At-The-Market Issuances Sales Agreement with Aegis Capital Corp. (effective 2024-04-26).

“On April 26, 2024, Flora Growth Corp. (the "Company") entered into an At-The-Market Issuances Sales Agreement (the "Sales Agreement") with Aegis Capital Corp. (the "Agent") pursuant to which the Company may sell from time to time, at its option, common shares through the Agent in its capacity as sales agent.”

ZeroStack Corp. completed an acquisition involving TruHC Holding GmbH for $6.4 million (closed 2024-04-22).

“On April 22, 2024, Flora Growth Corp. (the "Company") completed the first closing (the "First Closing") of the previously disclosed acquisition of TruHC Pharma GmbH in exchange for a total of 2,770,562 common shares of the Company valued at an aggregate of $6.4 million based on the closing price of the Company's common shares on March 28, 2024 of $2.31 per share”

ZeroStack Corp. entered into Stock Purchase Agreement with TruHC Holding GmbH (the "Seller") valued at $6.4 million (effective 2024-04-16).

“On April 16, 2024, Flora Growth Corp. (the "Company") entered into a Stock Purchase Agreement (the "Purchase Agreement") with TruHC Holding GmbH (the "Seller") pursuant to which the Company will acquire all of the issued and outstanding shares of TruHC Pharma GmbH in exchange for 2,770,562 common shares of the Company valued at an aggregate of $6.4 million (the "Purchase Price") based on the closing price of the Company's common shares on March 28, 2024 of $2.31 per share.”

ZeroStack Corp. entered into Agreement with TruHC Holding GmbH valued at US$6,400,000 (effective 2024-04-01).

“On April 1, 2024, Flora Growth Corp. (the "Flora") entered into a binding letter of intent (the "Agreement") with TruHC Holding GmbH (the "Seller") to acquire all of the issued and outstanding shares of TruHC Pharma GmbH (the "Transaction").”